The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
Abingdon, UK: Isansys Lifecare, the market leader in new generation wireless patient monitoring technology and patient digitisation systems and services, today announced the hiring of Sam Thwaites as its new UK Sales Manager, reporting to CEO Keith Errey.
Read the rest of entry »
Edinburgh, UK – Caldan Therapeutics, a spin-out company from the Universities of Glasgow and Southern Denmark, which specialises in developing novel therapeutics targeting free fatty acid receptors for the treatment of metabolic disease, including Type 2 Diabetes and non-alcoholic steatohepatitis (NASH), is pleased to announce the appointment of Dr Mark Payton as Chief Executive Officer (CEO).
Oxford, UK & San Jose, USA - Oxford BioTherapeutics (“OBT”), an international biotechnology company developing clinical stage antibody therapeutics for cancer, today announced a significant strengthening of its oncology focused Board of Directors with the appointment of Bernd Seizinger M.D., Ph.D. as Chairman and Jean-Pierre Bizzari, M.D. as a non-executive director, joining Glenn Begley, Shawn Tomasello, Tom Bradley and Christian Rohlff.
Birmingham & London, UK - SRG has appointed Marianna Suckova as Director of Clinical, based in London. Marianna Suckova brings extensive knowledge of Drug Development along with a notable pedigree in sales activities, recruitment, change management and people leadership.
Oxford, UK – Summit Therapeutics plc, the drug discovery and development company advancing therapies for Duchenne muscular dystrophy (‘DMD’) and C. difficile infection (‘CDI’), today announces the appointment of Dr David Roblin as Chief Operating Officer (‘COO’) and President of Research and Development.
Birmingham, UK - Science, clinical and engineering recruitment company SRG has appointed Marianna Suckova as Director of Clinical, based in London.
Oxford, UK - e-Therapeutics plc (AIM: ETX), the drug discovery company, announces that it has appointed Dr. Raymond Barlow as Chief Executive Officer. Dr. Barlow will take up the role on or before 1 May 2017, at which point he will be appointed to the e-Therapeutics Board of Directors.
14 December 2016: Loughborough, UK - CRO, Charnwood Molecular Ltd, appoints Dr James Hitchin as its new Head of Medicinal Chemistry to lead its research services laboratories at BioCity, Nottingham.
Dr Hitchin brings extensive experience from across multiple therapeutic areas in drug discovery to the Charnwood team. James has previously held positions at SAFC Pharma, Pfizer Pharmaceuticals and KemFine Oy. Most recently he was Senior Medicinal Chemist at the Cancer Research UK Manchester Institute, where he worked on various target classes, including kinases and epigenetic targets from hit identification right through to lead optimization and beyond.
“I am looking forward to the challenge of leading Charnwood Molecular’s Medicinal Chemistry division”, states James. “We are experiencing significant growth in our chemistry services business, including an increase in demand for the medicinal chemistry research that we undertake at the BioCity laboratories. Charnwood&rsquo ...
05 December 2016: Cambridge, UK - Kiss Communications have announced the appointment of Kate Matthews to the position of Head of PR. This is a new role, with Kate reporting into Sarah Reakes, Managing Director.
Kate has held several senior positions including Head of PR at Ware Anthony Rust in Cambridge, Board Director at Thirteen Communications and Associate Director at The Red Consultancy, both in London. She brings a wealth of management expertise and over 14 years’ experience in creating and leading integrated PR campaigns for B2B and B2C organisations. Kate’s client experience includes: Microscoft, Adobe, eBay, Flybe, Department for Education, ebookers, and learndirect.
Kate said: “The KISS promise to ‘clarify the complex’ really stood out to me – as more and more brands compete for space, the ability to create simple but impactful ideas that cut through the noise is a real must for any successful agency. I have been impressed with the team’s energy and ent ...
16 November 2016: Thame, UK - Horton International, Global Healthcare is pleased to announce that Declan Haverty has joined the UK arm of Horton International, the international Executive Search Organisation, as a Partner, where he will specialise in areas including pharmaceuticals and healthcare as well as IT/technology and business and professional services.
Declan joins us from Informed Decision, a hybrid search practice delivering mid-to-senior level searches internationally for a range of clients across within the healthcare and life sciences arena and beyond, also providing his deep recruitment experience as hands-on interim Head of Recruitment again for a range of clients.
Declan began his career with Price Waterhouse (now PwC) working across business sectors in technology management consultancy with a range of blue-chip corporate clients. After seven years, with experience of professional internal recruitment, he then joined Goodman Graham, a boutique technology search and selection f ...
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.
This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc. Just drop an email to us, email@example.com, and we will post.